KA/EN
Register
Medicines reference
Search
Search
Product

Synuxol-Nita

Favourites

Amoxicillin + Clavulanic Acid · NITA-FARM LLC

1 form: tablet. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
50 mg tablets N10 for dogs and cats, Tablet · Cat 0.5–1 kg Cat 0.5–1 kg 1/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Cat 1–2 kg Cat 1–2 kg 1/2 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Cat 2–3 kg Cat 2–3 kg 3/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Cat 3–4 kg Cat 3–4 kg 1 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Cat 4–5 kg Cat 4–5 kg 1 1/4 tablets
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Dog 0.5–1 kg Dog 0.5–1 kg 1/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Dog 1–2 kg Dog 1–2 kg 1/2 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Dog 2–3 kg Dog 2–3 kg 3/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Dog 3–4 kg Dog 3–4 kg 1 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
50 mg tablets N10 for dogs and cats, Tablet · Dog 4–5 kg Dog 4–5 kg 1 1/4 tablets
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 · twice daily; course according to diagnosis		 twice daily; course according to diagnosis Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Synuxol-Nita 50 mg tablets N10 for dogs and cats, Tablet

vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label: infections caused by amoxicillin-clavulanate-susceptible bacteria, 12.5 mg/kg combined twice daily by a quarter-tablet table for 0.5-5 kg
6.4/10
Situational / acceptable
vetman assessment

Synuxol-Nita

50 mg tablets N10 for dogs and cats
Assessed clinical scopeDog · Full dog label: infections caused by amoxicillin-clavulanate-susceptible bacteria, 12.5 mg/kg combined twice daily by a quarter-tablet table for 0.5-5 kg · oral
Care settingVeterinary prescription after diagnosis for oral treatment at home, with culture for recurrent or complicated infection
vetman score 6.4/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000915 · Verified on 21 Oct 2026

A situational, reasonable first-line antimicrobial for small dogs: the composition and dose follow established amoxicillin-clavulanate practice. Its weaknesses are the local-only registration and the lack of bioequivalence data.

Regulatory and scientific credibility5.0/10

The exact product is registered in Georgia (000915, valid to 2030) with a current NITA-FARM instruction; it has no EU, UK or US authorisation documented in the reviewed evidence, but its 4:1 composition and 12.5 mg/kg twice-daily dose match long-established authorised amoxicillin-clavulanate products.

Clinical efficacy6.5/10

Amoxicillin-clavulanate has strong independent evidence and is a WSAVA essential medicine and an ISCAID option for many skin, soft-tissue and urinary infections; the bioequivalence of this formulation is unproven.

Safety and tolerability7.5/10

The class is well tolerated; vomiting, diarrhoea and penicillin hypersensitivity are the main risks, and the label asks for benefit-risk assessment in pregnancy and lactation.

Clinical practicality7.0/10

Quarter-tablet steps twice daily suit dogs of 0.5-5 kg; larger dogs need another strength, and clavulanate tablets must be kept dry in the blister.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use with penicillin or cephalosporin hypersensitivity, and never give to rabbits, guinea pigs, hamsters, gerbils or chinchillas.
  • Amoxicillin-clavulanate is EU AMEG Category C (Caution): plain amoxicillin is usually preferred for sporadic cystitis, and topical therapy alone often suffices for superficial pyoderma.
  • Do not combine with the bacteriostatic antimicrobials listed on the label.
  • Watch for vomiting, diarrhoea or allergic reactions and recheck if signs do not improve within a few days.
  • Dose by the combined 12.5 mg/kg; this 50 mg tablet covers only 0.5-5 kg.
Assessment sources
  1. NITA-FARM Synuxol-Nita
  2. Georgia NFA register 20262026
  3. ISCAID pyoderma 20252025
  4. ISCAID urinary 20192019
  5. WSAVA essential medicines 20232023
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label: infections caused by amoxicillin-clavulanate-susceptible bacteria, 12.5 mg/kg combined twice daily by a quarter-tablet table for 0.5-5 kg
6.4/10
Situational / acceptable
vetman assessment

Synuxol-Nita

50 mg tablets N10 for dogs and cats
Assessed clinical scopeCat · Full cat label: infections caused by amoxicillin-clavulanate-susceptible bacteria, 12.5 mg/kg combined twice daily by a quarter-tablet table for 0.5-5 kg · oral
Care settingVeterinary prescription after diagnosis for oral treatment at home, with culture for recurrent or complicated infection
vetman score 6.4/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000915 · Verified on 21 Oct 2026

A situational, reasonable first-line antimicrobial for cats: the composition and dose follow established amoxicillin-clavulanate practice. Its weaknesses are the local-only registration, missing bioequivalence data and twice-daily pilling.

Regulatory and scientific credibility5.0/10

The exact product is registered in Georgia (000915, valid to 2030) with a current NITA-FARM instruction; it has no EU, UK or US authorisation documented in the reviewed evidence, but its 4:1 composition and 12.5 mg/kg twice-daily dose match long-established authorised amoxicillin-clavulanate products.

Clinical efficacy6.5/10

Amoxicillin-clavulanate has strong independent evidence in cats for bite abscesses, skin and urinary infections and is a WSAVA essential medicine; it does not cover Mycoplasma or Chlamydia, and this formulation's bioequivalence is unproven.

Safety and tolerability7.5/10

The class is well tolerated in cats; vomiting, diarrhoea and penicillin hypersensitivity are the main risks, and the label asks for benefit-risk assessment in pregnancy and lactation.

Clinical practicality6.5/10

Quarter-tablet steps fit cats of 0.5-5 kg well, but twice-daily pilling is harder in cats, and the tablets must be kept dry in the blister.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use with penicillin or cephalosporin hypersensitivity, and never give to rabbits, guinea pigs, hamsters, gerbils or chinchillas.
  • Amoxicillin-clavulanate is EU AMEG Category C (Caution): drain abscesses first, and use plain amoxicillin for sporadic cystitis where possible.
  • It does not treat Mycoplasma or Chlamydia felis; use doxycycline for those respiratory and eye infections.
  • Watch for vomiting, diarrhoea or allergic reactions and recheck if signs do not improve within a few days.
  • Dose by the combined 12.5 mg/kg; do not combine with the bacteriostatic antimicrobials listed on the label.
Assessment sources
  1. NITA-FARM Synuxol-Nita
  2. Georgia NFA register 20262026
  3. Feline antimicrobial consensus2025
  4. ISCAID urinary 20192019
  5. WSAVA essential medicines 20232023
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Amoxicillin40 mg Clavulanic Acid10 mg
Formulation Type
Tablet
Administration route
oral
Manufacturer
NITA-FARM LLC · Russia
Manufacturer (register)
Nita-farm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1460, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 11 Aug 2030
Veterinary (National Food Agency)
In the register: სინუქსოლ-ნიტა®
№ 000915
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Cat 0.5–1 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
1/2 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Cat 1–2 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
3/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Cat 2–3 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
1 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Cat 3–4 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
1 1/4 tablets
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Cat 4–5 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
1/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Dog 0.5–1 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
1/2 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Dog 1–2 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
3/4 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Dog 2–3 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
1 tablet
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Dog 3–4 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
1 1/4 tablets
The label dose is 12.5 mg/kg combined amoxicillin plus clavulanic acid. Antibacterial use requires veterinary diagnosis and stewardship. Do not combine with listed bacteriostatic antimicrobials; pregnancy/lactation require benefit-risk assessment.
 Dog 4–5 kg oral twice daily; course according to diagnosis
NITA-FARM Synuxol-Nita
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Synuxol-Nita 50 - current official instruction
Official manufacturer instruction
Active substance doses, with sources
Active substance Amoxicillin
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
10 mg/kg Dog, Cat Bacterial Infection By mouth 2 times daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Synulox palatable tablets 200 mg/50 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025
20 mg/kg Dog Respiratory Tract Infection By mouth 2 times daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Synulox Palatable Drops 40 mg/ml + 10 mg/ml, Powder for Oral Suspension - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025
7 mg/kg Dog, Cat Bacterial Infection Subcutaneous once daily for up to 5 days
Betamox 150 mg/ml, VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Betamox 150 mg/ml Suspension for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2026
Active substance Clavulanic Acid
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
2.5 mg/kg Dog, Cat Bacterial Infection By mouth 2 times daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Synulox palatable tablets 200 mg/50 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025

Known Contraindications

  • Critical Amoxicillin
    Do not use in cases of hypersensitivity to the active substances, other substances of the beta-lactam group or to any of the excipients.
    Sources: VMD SPC · VMD
  • Critical Amoxicillin
    Do not use in animals with severe renal impairment with anuria or oliguria.
    Sources: VMD SPC · VMD
  • Warning Amoxicillin
    The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
    Sources: VMD SPC · VMD
  • Warning Amoxicillin
    The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
    Sources: VMD SPC · VMD

Known Drug Interactions

  • Major warning Amoxicillin + Doxycycline
    The bactericidal effect of amoxicillin may be inhibited by the concomitant use of bacteriostatic antimicrobials.
    Recommendation: If both are required, support the choice with culture and susceptibility results. Otherwise, choose one mechanism.
    Sources: VMD SPC · VMD
  • Major warning Amoxicillin + Oxytetracycline
    Do not give oxytetracycline at the same time as bactericidal antimicrobials such as penicillins or cephalosporins because their antibacterial effects may be antagonistic.
    Recommendation: Do not administer concurrently.
  • Minor warning Amoxicillin + Dihydrostreptomycin
    Penicillins may increase the effect of aminoglycosides.
    Recommendation: An enhanced effect is expected; monitor for aminoglycoside toxicity. Do not mix in the same syringe.
    Sources: VMD SPC · VMD
  • Minor warning Amoxicillin + Trimethoprim/Sulfonamide
    Concurrent use of bactericidal beta-lactam antibiotics and bacteriostatic antimicrobials such as sulfonamides is generally not recommended because their effects may be antagonistic.
    Recommendation: Avoid concomitant administration.

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (59 more) Hide additional products

Same therapeutic group 59

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗